Neogen Corporation

NasdaqGS:NEOG 주식 보고서

시가총액: US$3.4b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Neogen 과거 수익 실적

과거 기준 확인 1/6

Neogen의 수입은 연평균 -37.7%의 비율로 감소해 온 반면, Medical Equipment 산업은 수입이 연평균 8.7%의 비율로 증가했습니다. 매출은 연평균 18.8%의 비율로 증가해 왔습니다. Neogen의 자기자본이익률은 0.05%이고 순이익률은 0.2%입니다.

주요 정보

-37.7%

수익 성장률

-37.9%

EPS 성장률

Medical Equipment 산업 성장8.9%
매출 성장률18.8%
자기자본 수익률0.05%
순이익0.2%
최근 수익 업데이트29 Feb 2024

최근 과거 실적 업데이트

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Recent updates

Neogen Corporation: Challenges Remain

Jun 26

There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

May 21
There's Reason For Concern Over Neogen Corporation's (NASDAQ:NEOG) Price

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Apr 15

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12
Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Mar 29
Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Mar 26

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Jan 17
Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12
Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Jan 09
Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Dec 06
Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Jul 12
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Jun 20
Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Mar 25
Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Oct 10

Neogen GAAP EPS of $0.05, revenue of $132.35M

Sep 27

Neogen drops 9% as merger with 3M’s food safety business closes

Sep 01

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Aug 21
Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Neogen: Cut In Half, Still Some Questions

Aug 12

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Aug 04
There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Aug 01

Neogen FQ4 2022 Earnings Preview

Jul 25

Zoetis, IDEXX named as buys in animal health space by Piper Sandler

Jul 13

Neogen announces pricing of $350M senior notes offering

Jul 07

Neogen: Safety Food Giant In The Making

Dec 15

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Dec 12
Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Sep 12
Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Robust Valuation Leaves Neogen Little Room For Error After Mixed Results

Jul 27

수익 및 비용 분석

Neogen 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NasdaqGS:NEOG 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
29 Feb 24929232224
30 Nov 239191235427
31 Aug 23919-2733628
31 May 23822-2328426
28 Feb 23721-1326723
30 Nov 22631-1618520
31 Aug 225313614518
31 May 225274814217
28 Feb 225144915417
30 Nov 215035713317
31 Aug 214876212817
31 May 214686112216
28 Feb 214506112016
30 Nov 204336011415
31 Aug 204266111315
31 May 204185911415
29 Feb 204195911415
30 Nov 194176011214
31 Aug 194166011214
31 May 194146011113
28 Feb 194136210911
30 Nov 184106510911
31 Aug 184036610711
31 May 183986310511
28 Feb 183895810411
30 Nov 173825210211
31 Aug 17372469911
31 May 17358449410
28 Feb 17353419510
30 Nov 16341399310
31 Aug 16330379010
31 May 16321378710
29 Feb 16310368410
30 Nov 15301358110
31 Aug 15290347910
31 May 15283347710
28 Feb 1527232759
30 Nov 1426531759
31 Aug 1425629739
31 May 1424728718
28 Feb 1423628688
30 Nov 1322528658
31 Aug 1321628638

양질의 수익: NEOG 에는 $63.7M 큰 일회성 손실이 있습니다. $63.7M 은 지난 12개월 간의 재무 결과에 29th February, 2024 까지 영향을 미쳤습니다.

이익 마진 증가: NEOG 는) 과거에 수익을 냈습니다.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: NEOG 의 수입은 지난 5년 동안 매년 37.7% 씩 감소했습니다.

성장 가속화: NEOG 지난해 흑자를 기록해 5년 평균과 비교하기 어려운 수익 성장률을 보이고 있습니다.

수익 대 산업: NEOG 작년에 수익을 올렸기 때문에 지난 해 수익 성장을 Medical Equipment 업계( 2.4% )와 비교하기가 어렵습니다.


자기자본 수익률

높은 ROE: NEOG 의 자본 수익률( 0.05% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기